Illumina’s third quarter results reflected stable year-over-year revenue and a notable beat on Wall Street’s profit ...

Illumina remains focused on achieving a positive resolution regarding its inclusion on the UEL and is committed to serving customers in this important market. For two decades, Illumina has been proud ...

Illumina Inc. said the Chinese government has lifted a ban on the company selling its DNA sequencing machines inside the country.

Hepta, a biotechnology company using transformer-based AI to read the cell-free DNA (cfDNA) epigenome and detect organ-specific signals of chronic disease, today emerged from stealth with $6.7 million ...

At the booth of Gilead Sciences, Lenacapavir, to be used as the world's only twice-yearly, long-acting injectable for HIV ...

Key opportunities in the precision oncology market include the rising adoption of personalized therapies, growth in ...